A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2011
10/26/2011	EP2379592A1 Antibodies against human angiopoietin 2
10/26/2011	EP2379576A1 HYDROSOLUBLE [6)-O-alpha-D-GLCP-(1->]n-6-O-beta-D-GLCP-(1->-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS
10/26/2011	EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011	EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011	EP2379558A1 Novel heterocyclic compounds for use as metap-2 inhibitors
10/26/2011	EP2379551A1 Substituted pyrazolo [3, 4-b]pyridine compounds
10/26/2011	EP2379549A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
10/26/2011	EP2379532A1 Compounds useful for inhibiting chk1
10/26/2011	EP2379530A1 Pyrimidine indole derivatives for treating cancer
10/26/2011	EP2379528A1 Protein kinase inhibitors
10/26/2011	EP2379520A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
10/26/2011	EP2379513A1 Heteroaryl compounds useful as raf kinase inhibitors
10/26/2011	EP2379506A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
10/26/2011	EP2379497A1 Hemifumarate salt of 1- ý4- ý1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl¨-2 -ethyl-benzyl¨-a zetidine-3-carboxylic acid
10/26/2011	EP2379493A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
10/26/2011	EP2379117A2 Cancer treatment
10/26/2011	EP2379114A1 Conjugates comprising nanoparticles coated with platinum containing compounds
10/26/2011	EP2379113A1 Methods of treating tumor cells using rhcc protein, fragment or variant
10/26/2011	EP2379103A1 Immunogenic composition and use thereof
10/26/2011	EP2379098A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011	EP2379097A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011	EP2379073A2 Methods for treating or preventing cancer and neurodegenerative diseases
10/26/2011	EP2379068A1 Compounds effective against cancer
10/26/2011	EP2379064A2 Long circulating nanoparticles for sustained release of therapeutic agents
10/26/2011	EP2379053A1 Prophylactic/therapeutic agent for cancer
10/26/2011	EP2176250B1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
10/26/2011	EP2136788B1 Cancer cell targeting using nanoparticles
10/26/2011	EP2131849B1 Compositions and methods for delivery of anti-cancer agents
10/26/2011	EP2061452B1 Anti cancer use of caffeic acid and derivatives
10/26/2011	EP2010152B1 Magnetic nanoparticles compositions and uses thereof
10/26/2011	EP1879611B1 Insp163 polypeptides and polynucleotides for the treatment or prevention of lung cancer
10/26/2011	EP1846394B1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/26/2011	EP1742964B1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
10/26/2011	EP1575509B1 Epha2 agonistic monoclonal antibodies and methods of use thereof
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	EP1352055B1 Map kinase integrin-binding domain
10/26/2011	EP1292321B1 Method to increase class i presentation of exogenous antigens by human dendritic cells
10/26/2011	EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/26/2011	EP1060247B2 Ox-40 receptor binding agent for use in methods for enhancing tumour antigen-specific immune response
10/26/2011	CN1868503B Preparation method of extractive of Herba Rabdosiae diterpene
10/26/2011	CN1607204B Cyclophosphamide quaternary ammonium salt derivant and its synthesis and use
10/26/2011	CN102227446A Anti-cmet antibody
10/26/2011	CN102227432A Process for preparing chlorins and their pharmaceutical uses
10/26/2011	CN102227429A 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/26/2011	CN102227426A Benzonaphtyridine compounds used as inhibitors of autotaxin
10/26/2011	CN102227422A Heterocyclic jak kinase inhibitors
10/26/2011	CN102227421A Anti-proliferation compounds
10/26/2011	CN102227410A Bis [o-(14-benzoylaconine-8-yl)] esters
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227226A Anti-igf antibodies
10/26/2011	CN102227222A Antitumor agent, method for production of said agent and method for stabilisation thereof
10/26/2011	CN102227221A Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor
10/26/2011	CN102227220A Hsp90 inhibitors for therapeutic treatment
10/26/2011	CN102227218A Tnik inhibitor and use thereof
10/26/2011	CN102226186A Activated Bax gene for treating malignant tumor by taking adenovirus as carrier
10/26/2011	CN102225962A New derivative bonded by berberine and cholic acid at 9th position of berberine and preparation method thereof
10/26/2011	CN102225961A Novel berberine 9-position coupled cholic acid derivative and preparation method thereof
10/26/2011	CN102225937A Antineoplastic alkaloid compound, and its medicine composition, preparation method and application
10/26/2011	CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011	CN102225925A Compound with activity for resisting chronic cell leukemia and preparation method thereof
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225921A Cyclopentane polyketide simplextone A and its application
10/26/2011	CN102225914A 3-alkenyl-4-aldehyde-5-aryl-4-isoxazoline compound, preparation method thereof and purpose thereof
10/26/2011	CN102225913A Rheinic acid derivatives and treatment application thereof
10/26/2011	CN102225209A Preparation method of nano magnetic granule composite system
10/26/2011	CN102225207A Dehydrocholic acid-molybdenum heteropoly salt-dehydrocholic acid compound and synthesis method thereof
10/26/2011	CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof
10/26/2011	CN102225204A Anti-tumour pH sensitive slow release implant and preparation method thereof
10/26/2011	CN102225201A New application of glycolytic inhibitor
10/26/2011	CN102225198A Anti-tumour medicine composition and preparation method and application thereof
10/26/2011	CN102225197A Application and extraction method of acrosin
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225183A Chinese traditional medicine composition for treating cancer and its preparation
10/26/2011	CN102225182A Traditional Chinese preparation capable of inhibiting tumor and enhancing immunity and preparation method thereof
10/26/2011	CN102225180A Traditional Chinese medicine composition having anticancer effect and preparation method thereof
10/26/2011	CN102225177A Chinese herbal medicine for treating cancer and preparation method thereof
10/26/2011	CN102225122A Caffeine-free tea polyphenol and preparation method thereof
10/26/2011	CN102225106A Propolis wine with berchemia lineate and preparation method thereof
10/26/2011	CN102225091A Method for preparing barbat skullcap total polyphenol
10/26/2011	CN102225089A Pharmaceutical composition for treating cancers, pharmaceutical preparation as well as applications and production methods thereof
10/26/2011	CN102225068A Anti-ovarian cancer effect of maslinic acid and medicinal preparation thereof
10/26/2011	CN102225067A Pharmaceutical composition for treating stomach cancer
10/26/2011	CN102225061A Use of isoflavone compound FHS in preparing cancer drug
10/26/2011	CN102225060A Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
10/26/2011	CN102225059A Application of mannitol in preparing antitumor medicines
10/26/2011	CN102225054A Preparation carried with particles of antitumor drug and preparation method thereof
10/26/2011	CN102225053A Vincristine nano targeting slow-release long-circulation liposome and preparation method thereof
10/26/2011	CN102225052A pH-sensitive doxorubicin nano-liposome and preparation method thereof
10/26/2011	CN102225051A pH sensitive doxorubicin nanoliposome modified by folic acid-carboxymethyl chitosan
10/26/2011	CN102225048A Curcumin compound injection and intravenous injection preparation thereof
10/26/2011	CN102058851B Medicament for treating cyclomastopathy and breast fibroadenoma
10/26/2011	CN101972283B Preparation method of common wedgelet fern herb total flavone
10/26/2011	CN101966221B Application of prickly pear in preparation of medicaments or health-care products
10/26/2011	CN101966207B Preparation method and content measuring method of macrothelypteris viridifrons total flavone with anti-tumor activity
10/26/2011	CN101919882B Application of red yeast rice to preparing abdominal aneurvsm medicine
10/26/2011	CN101897873B Preparation method of promoting blood circulation and removing blood stasis and soft dissolved extract
10/26/2011	CN101838311B Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
10/26/2011	CN101822819B Application of pumpkin protein to preparation of medicament for treating gastric cancer
10/26/2011	CN101817882B Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4E4 monoclonal antibody
10/26/2011	CN101676266B Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same

1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 2211